Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Thyroid cancer metastatic: Which Medications Are Safest? (66 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

66 medications are used for Thyroid cancer metastatic, with 524 combined adverse event reports. The most reported drugs for Thyroid cancer metastatic are LENVATINIB and CABOZANTINIB S-MALATE.

524
Total Reports
66
Drugs Used

All Medications for Thyroid cancer metastatic Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
LENVATINIB Lenvima 137 4,449 19,975 13.2%
CABOZANTINIB S-MALATE CABOMETYX 90 4,203 6,193 10.7%
SORAFENIB sorafenib 81 2,489 3,547 22.8%
DABRAFENIB Tafinlar 25 4,165 5,325 21.6%
VANDETANIB CAPRELSA 20 93 363 8.0%
PEMBROLIZUMAB KEYTRUDA 18 15,543 35,472 18.6%
PRALSETINIB Gavreto 17 226 431 15.9%
TRAMETINIB DIMETHYL SULFOXIDE Mekinist 17 3,925 3,438 24.1%
ENCORAFENIB BRAFTOVI 16 1,397 2,334 16.3%
BINIMETINIB MEKTOVI 15 1,069 1,990 15.5%
SELPERCATINIB RETEVMO 15 160 342 14.8%
SUNITINIB MALATE Sunitinib malate 15 6,028 5,720 27.9%
CARBOPLATIN Carboplatin 13 12,544 35,869 14.9%
PACLITAXEL PACLITAXEL PACLITAXEL 12 12,030 31,638 15.6%
LAROTRECTINIB VITRAKVI 8 149 151 18.7%
VEMURAFENIB ZELBORAF 8 1,040 2,368 12.1%
CISPLATIN CISplatin 7 8,387 17,469 17.7%
GEMCITABINE Gemcitabine 7 5,142 12,268 16.4%
OXALIPLATIN Oxaliplatin 7 6,501 21,980 11.5%
PAZOPANIB Pazopanib 7 5,612 4,347 26.5%

View all 66 drugs →

Most Reported Drugs for Thyroid cancer metastatic

#1 most reported
#2 most reported
#3 most reported